{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T06:34:09Z","timestamp":1724308449866},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00345-018-2456-7","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T06:13:47Z","timestamp":1535004827000},"page":"891-898","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modifications to Botulinum toxin A delivery in the management of detrusor overactivity recalcitrant to initial injections: a review"],"prefix":"10.1007","volume":"37","author":[{"given":"A.","family":"Doherty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. B.","family":"Hennessey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Onggo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Ranasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"issue":"4","key":"2456_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s003450050065","volume":"16","author":"CR Chapple","year":"1998","unstructured":"Chapple CR, Bryan NP (1998) Surgery for detrusor overactivity. World J Urol 16(4):268\u2013273","journal-title":"World J Urol"},{"issue":"8","key":"2456_CR2","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1464-410X.2011.10509.x","volume":"109","author":"PM Gurung","year":"2012","unstructured":"Gurung PM et al (2012) Long-term outcomes of augmentation ileocystoplasty in patients with spinal cord injury: a minimum of 10\u00a0years of follow-up. BJU Int 109(8):1236\u20131242","journal-title":"BJU Int"},{"issue":"4","key":"2456_CR3","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.juro.2013.04.075","volume":"190","author":"BJ Schlomer","year":"2013","unstructured":"Schlomer BJ, Saperston K, Baskin L (2013) National trends in augmentation cystoplasty in the 2000s and factors associated with patient outcomes. J Urol 190(4):1352\u20131357","journal-title":"J Urol"},{"issue":"9","key":"2456_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603\u2013605","journal-title":"Eur J Epidemiol"},{"issue":"17","key":"2456_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.purol.2015.07.006","volume":"25","author":"B Peyronnet","year":"2015","unstructured":"Peyronnet B et al (2015) Definition of botulinum toxin failure in neurogenic detrusor overactivity: preliminary results of the DETOX survey. Prog Urol 25(17):1219\u20131224","journal-title":"Prog Urol"},{"issue":"8","key":"2456_CR6","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/nau.21150","volume":"30","author":"I Makovey","year":"2011","unstructured":"Makovey I et al (2011) Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability. Neurourol Urodyn 30(8):1538\u20131540","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"2456_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/nau.22948","volume":"36","author":"RK Owen","year":"2017","unstructured":"Owen RK et al (2017) Patient factors associated with onabotulinum toxin A treatment outcome in women with detrusor overactivity. Neurourol Urodyn 36(2):426\u2013431","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"2456_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.eururo.2016.03.052","volume":"70","author":"L Leitner","year":"2016","unstructured":"Leitner L et al (2016) More than 15\u00a0years of experience with intradetrusor onabotulinumtoxinA injections for treating refractory neurogenic detrusor overactivity: lessons to be learned. Eur Urol 70(3):522\u2013528","journal-title":"Eur Urol"},{"issue":"2","key":"2456_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/nau.23352","volume":"37","author":"C Joussain","year":"2018","unstructured":"Joussain C et al (2018) Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxinA injections for the treatment of refractory neurogenic detrusor overactivity. Neurourol Urodyn 37(2):799\u2013806","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"2456_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.purol.2015.05.008","volume":"25","author":"M Lacout","year":"2015","unstructured":"Lacout M et al (2015) Seniority of neurobladder and effectiveness of a first intradetrusor injection of botulinum toxin. Prog Urol 25(11):642\u2013648","journal-title":"Prog Urol"},{"issue":"9","key":"2456_CR11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","volume":"45","author":"J Jankovic","year":"1995","unstructured":"Jankovic J, Schwartz K (1995) Response and immunoresistance to botulinum toxin injections. Neurology 45(9):1743\u20131746","journal-title":"Neurology"},{"issue":"7","key":"2456_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1185\/030079904125003962","volume":"20","author":"M Naumann","year":"2004","unstructured":"Naumann M, Jankovic J (2004) Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin 20(7):981\u2013990","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"2456_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.acuro.2013.02.002","volume":"37","author":"MG Lucas","year":"2013","unstructured":"Lucas MG et al (2013) EAU guidelines on surgical treatment of urinary incontinence. Actas Urol Esp 37(8):459\u2013472","journal-title":"Actas Urol Esp"},{"key":"2456_CR14","doi-asserted-by":"crossref","unstructured":"Cohen BL et al (2009) Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder. Adv Urol p. 328\u2013364","DOI":"10.1155\/2009\/328364"},{"key":"2456_CR15","doi-asserted-by":"crossref","unstructured":"Duthie JB (2011) Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev (12):p. CD005493","DOI":"10.1002\/14651858.CD005493.pub3"},{"issue":"3","key":"2456_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.eururo.2011.10.028","volume":"61","author":"P Denys","year":"2012","unstructured":"Denys P et al (2012) Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study. Eur Urol 61(3):520\u2013529","journal-title":"Eur Urol"},{"issue":"8","key":"2456_CR17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/nau.22376","volume":"32","author":"E Rovner","year":"2013","unstructured":"Rovner E et al (2013) OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity. Neurourol Urodyn 32(8):1109\u20131115","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"2456_CR18","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","volume":"187","author":"D Ginsberg","year":"2012","unstructured":"Ginsberg D et al (2012) Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol 187(6):2131\u20132139","journal-title":"J Urol"},{"issue":"4","key":"2456_CR19","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","volume":"60","author":"F Cruz","year":"2011","unstructured":"Cruz F et al (2011) Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 60(4):742\u2013750","journal-title":"Eur Urol"},{"issue":"5","key":"2456_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.eururo.2010.06.035","volume":"58","author":"P Grise","year":"2010","unstructured":"Grise P et al (2010) Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses. Eur Urol 58(5):759\u2013766","journal-title":"Eur Urol"},{"issue":"6","key":"2456_CR21","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00345-012-0984-0","volume":"31","author":"A Apostolidis","year":"2013","unstructured":"Apostolidis A et al (2013) An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity. World J Urol 31(6):1469\u20131474","journal-title":"World J Urol"},{"issue":"6","key":"2456_CR22","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","volume":"184","author":"R Dmochowski","year":"2010","unstructured":"Dmochowski R et al (2010) Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol 184(6):2416\u20132422","journal-title":"J Urol"},{"issue":"3","key":"2456_CR23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.eururo.2007.04.026","volume":"52","author":"B Schurch","year":"2007","unstructured":"Schurch B et al (2007) Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. Eur Urol 52(3):850\u2013858","journal-title":"Eur Urol"},{"issue":"3","key":"2456_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/nau.22293","volume":"32","author":"D Sussman","year":"2013","unstructured":"Sussman D et al (2013) Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity. Neurourol Urodyn 32(3):242\u2013249","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"2456_CR25","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.urology.2006.05.054","volume":"68","author":"HC Kuo","year":"2006","unstructured":"Kuo HC (2006) Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity? Urology 68(5):993\u2013997 discussion 997-8","journal-title":"Urology"},{"issue":"1","key":"2456_CR26","first-page":"35","volume":"67","author":"M Malki","year":"2014","unstructured":"Malki M et al (2014) What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU? Cent Eur J Urol 67(1):35\u201340","journal-title":"Cent Eur J Urol"},{"issue":"2","key":"2456_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00345-017-2121-6","volume":"36","author":"JK Jo","year":"2018","unstructured":"Jo JK et al (2018) The effect of onabotulinumtoxinA according to site of injection in patients with overactive bladder: a systematic review and meta-analysis. World J Urol 36(2):305\u2013317","journal-title":"World J Urol"},{"issue":"5 Suppl 1","key":"2456_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0090-4295(01)01637-5","volume":"59","author":"KE Andersson","year":"2002","unstructured":"Andersson KE (2002) Bladder activation: afferent mechanisms. Urology 59(5 Suppl 1):43\u201350","journal-title":"Urology"},{"issue":"3","key":"2456_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00345-008-0362-0","volume":"27","author":"U Mehnert","year":"2009","unstructured":"Mehnert U et al (2009) A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging. World J Urol 27(3):397\u2013403","journal-title":"World J Urol"},{"issue":"6","key":"2456_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/nau.22780","volume":"35","author":"CH Liao","year":"2016","unstructured":"Liao CH, Chen SF, Kuo HC (2016) Different number of intravesical onabotulinumtoxinA injections for patients with refractory detrusor overactivity do not affect treatment outcome: a prospective randomized comparative study. Neurourol Urodyn 35(6):717\u2013723","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"2456_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1569-9056(07)60885-9","volume":"6","author":"G Karsenty","year":"2007","unstructured":"Karsenty G, Carsenac A, Boy S, Reitz A, Bardot P, Tournebise H, Bladou F, Serment G, Schurch B (2007) 890 Botulinum toxin-A (BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI)-A prospective randomized study to compare 30 Vs. 10 injection sites. Eur Urol Suppl 6(2):245","journal-title":"Eur Urol Suppl"},{"issue":"4","key":"2456_CR32","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/nau.23052","volume":"36","author":"MA Avallone","year":"2017","unstructured":"Avallone MA et al (2017) Less is more-A pilot study evaluating one to three intradetrusor sites for injection of OnabotulinumtoxinA for neurogenic and idiopathic detrusor overactivity. Neurourol Urodyn 36(4):1104\u20131107","journal-title":"Neurourol Urodyn"},{"issue":"12","key":"2456_CR33","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/iju.12950","volume":"22","author":"B Peyronnet","year":"2015","unstructured":"Peyronnet B et al (2015) Failure of botulinum toxin injection for neurogenic detrusor overactivity: switch of toxin versus second injection of the same toxin. Int J Urol 22(12):1160\u20131165","journal-title":"Int J Urol"},{"issue":"2","key":"2456_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/nau.22712","volume":"35","author":"B Peyronnet","year":"2016","unstructured":"Peyronnet B et al (2016) Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity. Neurourol Urodyn 35(2):267\u2013270","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"2456_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/nau.23291","volume":"37","author":"F Bottet","year":"2018","unstructured":"Bottet F et al (2018) Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed. Neurourol Urodyn 37(1):291\u2013297","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"2456_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.eururo.2014.01.036","volume":"65","author":"HC Kuo","year":"2014","unstructured":"Kuo HC et al (2014) Pilot study of liposome-encapsulated onabotulinumtoxinA for patients with overactive bladder: a single-center study. Eur Urol 65(6):1117\u20131124","journal-title":"Eur Urol"},{"issue":"6","key":"2456_CR37","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.juro.2014.07.008","volume":"192","author":"YC Chuang","year":"2014","unstructured":"Chuang YC et al (2014) Bladder instillation of liposome encapsulated onabotulinumtoxinA improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial. J Urol 192(6):1743\u20131749","journal-title":"J Urol"},{"issue":"2","key":"2456_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.juro.2017.02.021","volume":"198","author":"YC Chuang","year":"2017","unstructured":"Chuang YC, Kuo HC (2017) A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis\/Bladder Pain Syndrome. J Urol 198(2):376\u2013382","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2456-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T16:00:45Z","timestamp":1567008045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2456-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2456"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2456-7","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]},"assertion":[{"value":"25 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No potential conflict of interest relevant to this article was reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"No ethical issues as this is a systematic review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}